VivaQuant is a digital health care company providing remote cardiac monitoring services to clinics and hospitals under the Rhythm Express brand. The Company’s highly differentiated mobile cardiac telemetry (MCT) wearable, the RX-1 mini, enables near real-time observation of a patient’s heart rhythm and can be comfortably worn for up to 30 days. The mini was designed from the ground up to provide the trifecta of wearables – a device that is easy to wear, easy to use, and provides accurate diagnostic data. The mini contains proprietary noise cancelling algorithms that result in high-clarity ECGs and our proprietary wavelet analytics, enabled by machine learning, provide near-perfect identification of cardiac arrhythmias and facilitate fast diagnosis. We provide 24/7/365 oversite of incoming patient data from the mini, where millions of heart beats are translated into actionable information that physicians can use as an aid in diagnosis and establishing life-saving care plans for patients.

Provided scientific leadership in research and development of implantable therapeutic and monitoring devices for arrhythmia, ischemia and heart failure. Member or technical lead in start-up teams focused on new therapies, such as subcutaneous defibrillator, neural stimulation therapy and non-invasive sensors. Technical leader for a strategic area in CRM patent portfolio. Member of technology identification committee. Study director or advisor on several preclinical and clinical studies.

Applied Artificial Intelligence tools to build supervised and unsupervised predictive models to assess and improve targeting and content of marketing programs.

Mathematical modelling and control of complex biological systems